Advertisement

Real-Time Bioluminescence Imaging of Viral Pathogenesis

  • Kathryn E. Luker
  • Gary D. Luker
Protocol
Part of the Methods in Molecular Biology™ book series (MIMB, volume 574)

Abstract

Mouse models are used commonly to study viral infection and define viral and host determinants of infection and disease morbidity. Conventional studies of viral infection in mice rely upon euthanizing cohorts of animals at multiple time points to identify sites of infection, quantify viral titers, and determine host immune responses. This experimental paradigm precludes longitudinal studies of infection and response to treatment in the same animal and assumes that progression of infection and pharmacodynamics of therapeutic agents are identical in all mice. To enable repetitive, quantitative studies of viral infection in mouse models, we and others are using noninvasive bioluminescence imaging to track viral infection, dissemination, and effects of host immune mediators on disease. In this chapter, we detail experimental protocols for bioluminescence imaging of viral infections in living mice.

Key words

Luciferase optical imaging vaccinia herpes simplex virus mouse model 

Notes

Acknowledgments

Infectious disease imaging research in the authors’ laboratory is supported by R21AI066192 and NIH R24CA083099 for the University of Michigan Small Animal Imaging Resource.

References

  1. 1.
    Luker, K., Hutchens, M., Schultz, T., Pekosz, A., and Luker, G. (2005) Bioluminescence imaging of vaccinia virus: effects of interferon on viral replication and spread. Virology 341, 284–300.PubMedCrossRefGoogle Scholar
  2. 2.
    Hutchens, M., Luker, K., Sottile, P., Sonstein, J., Lukacs, N., Nunez, G., Curtis, J., and Luker, G. (2008) TLR3 increases disease morbidity and mortality from vaccinia infection. J Immunol 180, 483–491.PubMedGoogle Scholar
  3. 3.
    Cook, S., and Griffin, D. (2003) Luciferase imaging of a neurotropic viral infection in intact animals. J Virol 77, 5333–5338.PubMedCrossRefGoogle Scholar
  4. 4.
    Pierson, T., Diamond, M., Ahmed, A., Valentine, L., Davis, C., Samuel, M., Hanna, S., Puffer, B., and Doms, R. (2005) An infectious West Nile virus that expresses a GFP reporter gene. Virology 334, 28–40.PubMedCrossRefGoogle Scholar
  5. 5.
    Zhao, H., Doyle, T., Coquoz, O., Kalish, F., Rice, B., and Contag, C. (2005) Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo. J Biomed Optics 10, 41210.CrossRefGoogle Scholar
  6. 6.
    Bhaumik, S., and Gambhir, S. (2002) Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc Natl Acad Sci USA 99, 377–382.PubMedCrossRefGoogle Scholar
  7. 7.
    Tannous, B., Kim, D., Fernandez, J., Weissleder, R., and Breakefield, X. (2005) Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 11, 435–443.PubMedCrossRefGoogle Scholar
  8. 8.
    Loening, A., Wu, A., and Gambhir, S. (2007) Red-shifted Renilla reniformis luciferase variants for imaging in living subjects. Nat Methods 4, 641–643.PubMedCrossRefGoogle Scholar
  9. 9.
    Luker, G., Bardill, J., Prior, J., Pica, C., Piwnica-Worms, D., and Leib, D. (2002) Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J Virol 76, 12149–12161.PubMedCrossRefGoogle Scholar
  10. 10.
    Saxena, M., Aton, F., Hildebolt, C., Prior, J., Abraham, U., Piwnica-Worms, D., and Herzog, E. (2007) Bioluminescence imaging of period1 gene expression in utero. Mol Imaging 6, 68–72.PubMedGoogle Scholar
  11. 11.
    Zhao, H., Doyle, T., Wong, R., Cao, Y., Stevenson, D., Piwnica-Worms, D., and Contag, C. (2004) Characterization of coelenterazine analogs for measurements of Renilla luciferase activity in live cells and living animals. Mol Imaging 3, 43–54.PubMedCrossRefGoogle Scholar
  12. 12.
    Pichler, A., Prior, J., and Piwnica-Worms, D. (2004) Imaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelenterazine. Proc Natl Acad Sci USA 101, 1702–1707.PubMedCrossRefGoogle Scholar
  13. 13.
    Paroo, Z., Bollinger, R., Braasch, D., Richer, E., Corey, D., Antich, P., and Mason, R. (2004) Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden. Mol imaging 3, 117–124.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Kathryn E. Luker
    • 1
  • Gary D. Luker
    • 1
  1. 1.Departments of Radiology and Microbiology and ImmunologyUniversity of Michigan Medical SchoolAnn ArborUSA

Personalised recommendations